Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice

Oncogene

Volumn 30, Issue 43, 2011, Pages 4428-4436

  Nitzki, F ^a   Zibat, A ^a   Frommhold, A ^a   Schneider, A ^b   Schulz Schaeffer, W ^a   Braun, T ^b   Hahn, H ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

ERMS; hedgehog; patched1; rhabdomyosarcoma; time of initiation

Indexed keywords

PROTEIN PATCHED 1; TAMOXIFEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL FATE; CELL TRANSFORMATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; EMBRYONAL RHABDOMYOSARCOMA; FEMALE; FETUS; GENE DELETION; GENE INACTIVATION; GENE MUTATION; HETEROZYGOTE; MOUSE; MOUSE MUTANT; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROPENSITY SCORE; STEM CELL;

ANIMALS; EMBRYONIC DEVELOPMENT; GENE KNOCKOUT TECHNIQUES; HETEROZYGOTE; MICE; MICE, INBRED BALB C; MUTATION; MYOGENIC REGULATORY FACTOR 5; RECEPTORS, CELL SURFACE; RHABDOMYOSARCOMA, EMBRYONAL; STEM CELLS; TIME FACTORS;

ERINACEIDAE; MUS;

EID: 80055056242     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.157     Document Type: Article

References (39)

1. Asakura A, Tapscott SJ. (1998). Apoptosis of epaxial myotome in Danforth's short-tail (Sd) mice in somites that form following notochord degeneration. Dev Biol 203: 276-289. (Pubitemid 28536644)
2. Biressi S, Molinaro M, Cossu G. (2007a). Cellular heterogeneity during vertebrate skeletal muscle development. Dev Biol 308: 281-293. (Pubitemid 47223117)
3. Biressi S, Tagliafico E, Lamorte G, Monteverde S, Tenedini E, Roncaglia E et al. (2007b). Intrinsic phenotypic diversity of embryonic and fetal myoblasts is revealed by genome-wide gene expression analysis on purified cells. Dev Biol 304: 633-651. (Pubitemid 46546388)
4. Braun T, Bober E, Rudnicki MA, Jaenisch R, Arnold HH. (1994). MyoD expression marks the onset of skeletal myogenesis in Myf-5 mutant mice. Development 120: 3083-3092. (Pubitemid 24343241)
5. Braun T, Rudnicki MA, Arnold HH, Jaenisch R. (1992). Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell 71: 369-382.
6. Calzada-Wack J, Kappler R, Schnitzbauer U, Richter T, Nathrath M, Rosemann M et al. (2002). Unbalanced overexpression of the mutant allele in murine Patched mutants. Carcinogenesis 23: 727-734.
7. Danielian PS, Muccino D, Rowitch DH, Michael SK, McMahon AP. (1998). Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr Biol 8: 1323-1326. (Pubitemid 29006707)
8. Diwan BA, Anderson LM, Ward JM. (1997). Proliferative lesions of oviduct and uterus in CD-1 mice exposed prenatally to tamoxifen. Carcinogenesis 18: 2009-2014. (Pubitemid 28132388)
9. Ecke I, Petry F, Rosenberger A, Tauber S, Monkemeyer S, Hess I et al. (2009). Antitumor effects of a combined 5-aza-20deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice. Cancer Res 69: 887-895.
10. Evangelista M, Tian H, de Sauvage FJ. (2006). The hedgehog signaling pathway in cancer. Clin Cancer Res 12: 5924-5928. (Pubitemid 44703749)
11. Gensch N, Borchardt T, Schneider A, Riethmacher D, Braun T. (2008). Different autonomous myogenic cell populations revealed by ablation of Myf5-expressing cells during mouse embryogenesis. Development 135: 1597-1604. (Pubitemid 351895489)
12. Goodrich LV, Johnson RL, Milenkovic L, McMahon JA, Scott MP. (1996). Conservation of the hedgehog/patched signaling pathway from flies to mice: induction of a mouse patched gene by Hedgehog. Genes Dev 10: 301-312. (Pubitemid 26058963)
13. Gorlin RJ. (1987). Nevoid basal-cell carcinoma syndrome. Medicine (Baltimore) 66: 98-113. (Pubitemid 17059640)
14. Gustafsson MK, Pan H, Pinney DF, Liu Y, Lewandowski A, Epstein DJ et al. (2002). Myf5 is a direct target of long-range Shh signaling and Gli regulation for muscle specification. Genes Dev 16: 114-126. (Pubitemid 34049642)
15. Hahn H, Christiansen J, Wicking C, Zaphiropoulos PG, Chidambaram A, Gerrard B et al. (1996). A mammalian patched homolog is expressed in target tissues of sonic hedgehog and maps to a region associated with developmental abnormalities. J Biol Chem 271: 12125-12128. (Pubitemid 26160866)
16. Hahn H, Nitzki F, Schorban T, Hemmerlein B, Threadgill D, Rosemann M. (2004). Genetic mapping of a Ptch1-associated rhabdomyosarcoma susceptibility locus on mouse chromosome 2. Genomics 84: 853-858. (Pubitemid 39314445)
17. Hahn H, Wojnowski L, Zimmer AM, Hall J, Miller G, Zimmer A. (1998). Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nature Med 4: 619-622. (Pubitemid 28237364)
18. Hameyer D, Loonstra A, Eshkind L, Schmitt S, Antunes C, Groen A et al. (2007). Toxicity of ligand-dependant Cre-recombinases and generation of a conditional Cre-deleter mouse allowing mosaic recombination in peripheral tissues. Physiol Genomics 31: 32-41. (Pubitemid 47443846)
19. Hooper JE, Scott MP. (2005). Communicating with Hedgehogs. Nat Rev Mol Cell Biol 6: 306-317. (Pubitemid 40516897)
20. Kappler R, Bauer R, Calzada-Wack J, Rosemann M, Hemmerlein B, Hahn H. (2004). Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma. Oncogene 23: 8785-8795. (Pubitemid 39593293)
21. Keller C, Arenkiel BR, Coffin CM, El-Bardeesy N, DePinho RA, Capecchi MR. (2004a). Alveolar rhabdomyosarcomas in conditional Pax3: Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. Genes Dev 18: 2614-2626. (Pubitemid 39453101)
22. Keller C, Hansen MS, Coffin CM, Capecchi MR. (2004b). Pax3: Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin. Genes Dev 18: 2608-2613. (Pubitemid 39453100)
23. Kruger M, Mennerich D, Fees S, Schafer R, Mundlos S, Braun T. (2001). Sonic hedgehog is a survival factor for hypaxial muscles during mouse development. Development 128: 743-752. (Pubitemid 32229251)
24. Langenau DM, Keefe MD, Storer NY, Guyon JR, Kutok JL, Le X et al. (2007). Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev 21: 1382-1395. (Pubitemid 46871041)
25. McDermott A, Gustafsson M, Elsam T, Hui CC, Emerson Jr CP, Borycki AG. (2005). Gli2 and Gli3 have redundant and contextdependent function in skeletal muscle formation. Development 132: 345-357. (Pubitemid 40268284)
26. Merlino G, Helman LJ. (1999). Rhabdomyosarcoma-working out the pathways. Oncogene 18: 5340-5348.
27. Merlino G, Khanna C. (2007). Fishing for the origins of cancer. Genes Dev 21: 1275-1279. (Pubitemid 46871031)
28. Nagao K, Togawa N, Fujii K, Uchikawa H, Kohno Y, Yamada M et al. (2005). Detecting tissue-specific alternative splicing and disease-associated aberrant splicing of the PTCH gene with exon junction microarrays. Hum Mol Genet 14: 3379-3388. (Pubitemid 41672122)
29. Resende TP, Ferreira M, Teillet MA, Tavares AT, Andrade RP, Palmeirim I. (2010). Sonic hedgehog in temporal control of somite formation. Proc Natl Acad Sci USA 107: 12907-12912.
30. Rivera OJ, Cho MJ, Arenkiel BR, Milenkovic L, Capecchi MR, Scott MP et al. (2006). Medulloblastoma but not rhabdomyosarcoma in a conditional mouse model of Patched1 haploinsufficiency. Abstract no. 2742; 97th AACR Annual Meeting; 1-5 April 2006; Washington, DC.
31. Tallquist MD, Weismann KE, Hellstrom M, Soriano P. (2000). Early myotome specification regulates PDGFA expression and axial skeleton development. Development 127: 5059-5070. (Pubitemid 32000664)
32. Taniguchi E, Cho MJ, Arenkiel BR, Hansen MS, Rivera OJ, McCleish AT et al. (2009). Bortezomib reverses a post-translational mechanism of tumorigenesis for patched1 haploinsufficiency in medulloblastoma. Pediatr Blood Cancer 53: 136-144.
33. Tostar U, Malm CJ, Meis-Kindblom JM, Kindblom LG, Toftgard R, Unden AB. (2006). Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development. J Pathol 208: 17-25. (Pubitemid 43025700)
34. Uhmann A, Dittmann K, Nitzki F, Dressel R, Koleva M, Frommhold A et al. (2007). The Hedgehog receptor Patched controls lymphoid lineage commitment. Blood 110: 1814-1823. (Pubitemid 47443892)
35. Uhmann A, Ferch U, Bauer R, Tauber S, Arziman Z, Chen C et al. (2005). A model for PTCH1/Ptch1-associated tumors comprising mutational inactivation and gene silencing. Int J Oncol 27: 1567-1575.
36. Varjosalo M, Taipale J. (2008). Hedgehog: functions and mechanisms. Genes Dev 22: 2454-2472.
37. Yang ZJ, Ellis T, Markant SL, Read TA, Kessler JD, Bourboulas M et al. (2008). Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell 14: 135-145.
38. Zibat A, Missiaglia E, Rosenberger A, Pritchard-Jones K, Shipley J, Hahn H et al. (2010). Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma. Oncogene 29: 6323-6330.
39. Zibat A, Uhmann A, Nitzki F, Wijgerde M, Frommhold A, Heller T et al. (2009). Time-point and dosage of gene inactivation determine the tumor spectrum in conditional Ptch knockouts. Carcinogenesis 30: 918-926.